GT
41
-4
WM
68
3
PEG
57
4
NOC
34
-6
DTE
58
2
RRC
70
-2
F
54
2
IR
74
2
TAP
41
-2
EMC
87
14
O
37
7
NWL
41
-3
LMT
55
6
DHI
29
5
T
68
2
MKC
59
3
EXR
62
7
BDX
32
2
LYB
22
2
PYPL
77
2
GT
41
-4
WM
68
3
PEG
57
4
NOC
34
-6
DTE
58
2
RRC
70
-2
F
54
2
IR
74
2
TAP
41
-2
EMC
87
14
O
37
7
NWL
41
-3
LMT
55
6
DHI
29
5
T
68
2
MKC
59
3
EXR
62
7
BDX
32
2
LYB
22
2
PYPL
77
2
Financhill
Back

Ascendis Pharma AS Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35

ASND
Ascendis Pharma AS

Last Price:
$157.40
Seasonality Move:
2.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Ascendis Pharma AS Stock Forecast

  • Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 33.7% based on the past 10 years of stock performance.
  • Ascendis Pharma AS has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
  • Is Ascendis Pharma AS Stock Undervalued?
    The current Ascendis Pharma AS [ASND] share price is $157.60. The Score for ASND is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Ascendis Pharma AS Stock Go Up Next Year?

  • Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 33.7% based on the past 10 years of stock performance.

Ascendis Pharma AS Stock Rating

Sell
35
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS overpriced?

  • Ascendis Pharma AS has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Ascendis Pharma AS Stock Price History

Is ASND stock going to rise?

  • The current trend is moderately bearish and ASND is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com

52-Week Data

52-Week High:
183.00
52-Week Low:
111.09

Prediction Charts

Market Cap:
9.5B
Price in USD:
157.60
Volume:
502.2K
Beta:
0.61

Technical Analysis

SMA50:
157.20
SMA100:
147.00
SMA200:
139.69
52-Wk Change:
28.34%

Stock Predictions

  • Is Ascendis Pharma AS stock public?
    Yes, Ascendis Pharma AS is a publicly traded company.
  • What is the Ascendis Pharma AS stock quote today?
    The Ascendis Pharma AS stock price is 157.60 USD today.
  • How to buy Ascendis Pharma AS stock online?
    You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 165.10 166.58 168.96 165.00
Apr-30 166.02 170.44 171.34 164.24
May-1 171.00 167.47 173.00 164.52
May-2 168.00 172.06 183.00 166.96
May-5 175.60 170.74 175.60 169.44
May-6 169.49 162.84 171.46 161.77
May-7 162.31 160.99 164.81 160.01
May-8 161.10 159.39 162.71 156.02
May-9 159.45 151.25 161.39 151.11
May-12 153.41 154.43 158.33 152.45
May-13 155.20 161.52 162.30 154.64
May-14 161.78 157.20 165.26 156.28
May-15 157.14 157.54 159.03 150.89
May-16 155.01 157.60 160.56 154.80

Ascendis Pharma AS Earnings

Ascendis Pharma AS Earnings Report: Per Share Ascendis Pharma AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ascendis Pharma AS Forecast Revenue Growth

Ascendis Pharma AS Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.59 per share, an increase this year of $2.02 per share, and an increase next year of $7.29 per share.

* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.